ResearcherZhejiang Provincial People's HospitalActive in the last 2 years
Xinbing Sui
Matched on ORCID iD 0000-0001-7330-0467; OpenAlex author ID A5015970814. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 4
- Butein suppresses pancreatic cancer progression by downregulating CDK2 and disrupting CDK2/CyclinA2 interaction. Last author DOI 10.1016/j.bcp.2026.118099↗
- Tetrahydromagnolol induces autophagic cell death by targeting the m6A reader protein YTHDF2 and enhances the efficacy of anti-PD-1 immunotherapy in pancreatic … Last author DOI 10.7150/thno.112612↗
- PLA2G16 expression predicts prognosis and gemcitabine sensitivity in patients with pancreatic cancer. Co-author DOI 10.7717/peerj.19517↗
- Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance. Co-author DOI 10.1016/j.hbpd.2022.12.002↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yiping Mou · 2 shared papers, 2023–2025 · strength 0.40
- Paper Tetrahydromagnolol induces autophagic cell death by targeting the m6A reader protein YTHDF2 and enhances the efficacy o… DOI 10.7150/thno.112612↗
- Paper Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance. DOI 10.1016/j.hbpd.2022.12.002↗
- Xiaoyu Sun · 1 shared paper, 2025 · strength 0.27
- Yucheng Zhou · 1 shared paper, 2025 · strength 0.27
- Mengting Chen · 1 shared paper, 2026 · strength 0.26
- Guohua Li · 1 shared paper, 2025 · strength 0.21
- Jiang Xiao-yin · 1 shared paper, 2023 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.